Cite
Chronic Rho-kinase inhibition improves left ventricular contractile dysfunction in early type-1 diabetes by increasing myosin cross-bridge extension
MLA
Waddingham, Mt, et al. Chronic Rho-Kinase Inhibition Improves Left Ventricular Contractile Dysfunction in Early Type-1 Diabetes by Increasing Myosin Cross-Bridge Extension. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1315666372&authtype=sso&custid=ns315887.
APA
Waddingham, M., Edgley, A., Astolfo, A., Inagaki, T., Fujii, Y., Du, C.-K., Zhan, D.-Y., Tsuchimochi, H., Yagi, N., Kelly, D., Shirai, M., & Pearson, J. (2015). Chronic Rho-kinase inhibition improves left ventricular contractile dysfunction in early type-1 diabetes by increasing myosin cross-bridge extension.
Chicago
Waddingham, Mt, Aj Edgley, A Astolfo, T Inagaki, Y Fujii, C-K Du, D-Y Zhan, et al. 2015. “Chronic Rho-Kinase Inhibition Improves Left Ventricular Contractile Dysfunction in Early Type-1 Diabetes by Increasing Myosin Cross-Bridge Extension.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1315666372&authtype=sso&custid=ns315887.